Saffron Pharma
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of New Mometasone Furoate Nasal Spray Formulation in Acute Rhinosinusitis Patients: A Randomized Clinical Trial (NCT05639959) | Saffron Pharma | 2022-09-10 |
Track Saffron Pharma automatically
Every clearance here is in the API, with alerts when new ones post.